Ocugen, Inc. announces closing of $ 23 million registered direct share offering
MALVERN, Pa., February 10, 2021 (GLOBE NEWSWIRE) – Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focusing on discovering, developing and commercializing gene therapies to cure blin…
